BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Serina Therapeutics Inc. – Indentures

NYSE American: SER    
Share price (6/2/26): $1.76    
Market cap (6/2/26): $26.4 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 14 pages New Form of Warrant Agreement
12/34/56
EX-4.2
from 8-K 14 pages Redeemable Common Stock Purchase Warrant Serina Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Serina Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 13 pages Warrant Agreement Between Serina Therapeutics, Inc. and [●]
12/34/56
EX-4.1
from 8-K 2 pages Description of Securities
12/34/56
EX-4.1
from S-3 11 pages Agreement
12/34/56
EX-4.2
from S-3 36 pages Serina Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.1
from S-3 35 pages Serina Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.5
from 10-K 5 pages Warrant Certificate
12/34/56
EX-4.4
from 10-K 5 pages Warrant Certificate
12/34/56
EX-4.2
from 10-Q 12 pages AgeX Therapeutics, Inc. Amended and Restated Certificate of Designation of Series B Preferred Stock, Setting Forth the Powers, Preferences, Rights, Qualifications, Limitations and Restrictions of Such Series of Preferred Stock
12/34/56
EX-4.1
from 10-Q 12 pages AgeX Therapeutics, Inc. Amended and Restated Certificate of Designation of Series a Preferred Stock, Setting Forth the Powers, Preferences, Rights, Qualifications, Limitations and Restrictions of Such Series of Preferred Stock
12/34/56
EX-4.2
from 8-K 12 pages AgeX Therapeutics, Inc. Certificate of Designation of Series B Preferred Stock, Setting Forth the Powers, Preferences, Rights, Qualifications, Limitations and Restrictions of Such Series of Preferred Stock
12/34/56
EX-4.1
from 8-K 11 pages AgeX Therapeutics, Inc. Certificate of Designation of Series a Preferred Stock, Setting Forth the Powers, Preferences, Rights, Qualifications, Limitations and Restrictions of Such Series of Preferred Stock
12/34/56
EX-4.4
from 10-K 1 page Description of Securities
12/34/56
EX-4.1
from 8-K 5 pages AgeX Therapeutics, Inc. Common Stock Purchase Warrants
12/34/56
EX-4.3
from 10-K 1 page Description of Securities
12/34/56
EX-4.1
from 10-Q 5 pages Certificate No. AGE 2019-1 Warrant to Purchase 150,000 Shares of Common Stock AgeX Therapeutics, Inc. Common Stock Purchase Warrants
12/34/56
EX-4.2
from 10-K 20 pages Warrant Agreement Dated as of February 28, 2018
12/34/56
EX-4.1
from 10-12B/A 3 pages Indenture or similar
12/34/56